FLUDARA ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	4

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04561557 (ClinicalTrials.gov)	September 22, 2020	10/9/2020	Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Idiopathic Inflammat ...	An Open Label Clinical Trial to Evaluate the Safety and Efficacy of CT103A Cells for the Treatment o ...	Autoimmune Diseases;Autoimmune Diseases of the Nervous System;Neuromyelitis Optica Spectrum Disorder ...	Biological: CT103A cells;Drug: Cyclophosphamide and fludarabine	Tongji Hospital	Nanjing IASO Biotherapeutics Co.,Ltd	Recruiting	18 Years	75 Years	All	18	Early Phase 1	China
2	NCT02529839 (ClinicalTrials.gov)	October 2015	10/6/2015	Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone ...	Safety and Efficacy of an Immunoablative Nonmyeloablative Conditioning Protocol for Autologous Bone ...	Multiple Sclerosis	Procedure: Autologous bone marrow transplantation;Drug: Fludarabine;Drug: Cyclophosphamide;Drug: Ale ...	Hadassah Medical Organization	NULL	Not yet recruiting	18 Years	65 Years	Both	20	N/A	NULL
3	NCT01679041 (ClinicalTrials.gov)	November 2012	29/8/2012	High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Trea ...	A Phase II Study of High Dose Chemotherapy With Autologous Hematopoietic Progenitor Cell Transplant ...	Multiple Sclerosis	Drug: Alemtuzumab;Drug: Fludarabine;Drug: Cyclophosphamide	Seah Lim M.D.	NULL	Terminated	18 Years	60 Years	Both	1	Phase 2	United States
4	EUCTR2008-005773-35-IT (EUCTR)		15/01/2013	AUTOLOUGUS STEM CELLS TRANSPLANTATION AFTER LINFOCYTE DEPLETION AS A NEW THERAPY FOR THE AGGRESSIVE ...	AUTOLOUGUS STEM CELLS TRANSPLANTATION AFTER LINFOCYTE DEPLETION AS A NEW THERAPY FOR THE AGGRESSIVE ...	MULTIPLE SCLEROSIS MedDRA version: 15.1;Level: LLT;Classification code 10028053;Term: MS;System Orga ...	Trade Name: ENDOXAN BAXTER INN or Proposed INN: Cyclophosphamide Trade Name: FLUDARA INN or Proposed IN ...	AZIENDA OSPEDALIERA DI PADOVA	NULL	NA			Female: yes Male: yes		Phase 1	Italy

First Previous1Next Last